RuCu Nanosheets with Ultrahigh Nanozyme Activity for Chemodynamic Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37053081.
- Also identified by DOI 10.1002/adhm.202300490.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanoenzymes have been widely explored for chemodynamic therapy (CDT) in cancer treatment. However, poor catalytic efficiency of nanoenzymes, especially in the tumor microenvironment with insufficient H<sub>2</sub> O<sub>2</sub> and mild acidity, limits the effect of CDT. Herein, a new ultrathin RuCu nanosheet (NS) based nanoenzyme which has a large specific surface area and abundant channels and defects is developed. The RuCu NSs show superb catalytic efficiency for the oxidation of peroxidase substrate H<sub>2</sub> O<sub>2</sub> at a wide range of pH and their catalytic efficiency (k<sub>cat</sub> /K<sub>m</sub> = 177.2 m<sup>-1</sup> s<sup>-1</sup> ) is about 14.9 times higher than that of the single-atom catalyst FeN<sub>3</sub> P. Besides being an efficient nanozyme as peroxidase, the RuCu NSs possess other two enzyme activities, not only disproportionating superoxide anion to produce H<sub>2</sub> O<sub>2</sub> but also consuming glutathione to keep a high concentration of H<sub>2</sub> O<sub>2</sub> in the tumor microenvironment for Fenton reaction. With these advantages, the RuCu NSs exhibit good performance to kill cancer cells and inhibit tumor growth in mice, demonstrating a promising potential as new CDT reagent.
Medical subject headings
- Peroxidase
- Neoplasms